In this line, the attachment of TRAIL to the surface of liposomes, an improvement proposed by our group, resulted in increased anti-tumor bioactivity, and in fact tried to mimic the natural way of secretion of TRAIL and FasL bound to exosomes, described initially in human T cell blasts [32,33,34]. The gene discussed is TNFSF10; the disease is neoplasm.